• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A multicenter model for examining in vitro susceptibilities of bacteria to antibiotics.

作者信息

Day D, Mangi R, Jenkins S, Ivey M F

出版信息

Hosp Formul. 1989 Sep;24(9):513-6, 519-20, 523.

PMID:10294666
Abstract

In vitro bacterial susceptibility data are often considered in both hospital formulary and antibiotic prescribing decisions. In this multicenter study, susceptibility data from 105 United States hospitals resulted in a database containing 211,142 isolates for 31 different bacteria and 38 antibiotics. To identify susceptibility patterns of bacteria to antibiotic alternatives, this computerized database was subjected to confidence interval analysis, while controlling for potential sources of random error. This paper describes the multicenter study design and provides several examples of the type of information the analysis can provide to P & Committee members and to practitioners who ultimately must make decisions regarding antibiotic use, sometimes without the benefit of complete hospital-specific historical antibiogram data. Limitations on the interpretation of aggregate in vitro susceptibility data gained from multiple institutions are also discussed.

摘要

相似文献

1
A multicenter model for examining in vitro susceptibilities of bacteria to antibiotics.
Hosp Formul. 1989 Sep;24(9):513-6, 519-20, 523.
2
The role of the microbiology laboratory in guiding formulary decisions.微生物实验室在指导处方集决策中的作用。
Hosp Formul. 1988 Aug;23(8):654-7.
3
A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.一个用于确定、沟通和管理抗生素处方集的多学科流程。
Hosp Pharm. 1992 Oct;27(10):867-9, 872-4, 882.
4
Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins.抗菌治疗中的争议:关于第三代头孢菌素的处方集决策
Am J Hosp Pharm. 1986 Mar;43(3):625-9.
5
The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.微生物学和药学部门在欧洲医院抗生素处方管理中的作用。
J Hosp Infect. 2007 Jun;65 Suppl 2:73-81. doi: 10.1016/S0195-6701(07)60019-X.
6
Formulary decision making: identifying factors that influence P&T committee drug evaluations.处方集决策:识别影响药品与治疗学委员会药物评估的因素。
Hosp Formul. 1988 Feb;23(2):174-8.
7
P&T Committee antibiotic cost considerations.
Hosp Formul. 1986 Aug;21(8):857-9, 862-4.
8
Cephalosporin selection: view from a beleaguered P & T committee member.
Hosp Formul. 1986 Jan;21(1):76-8, 83-4.
9
Antibiotic therapy 1985: what are the challenges?1985年的抗生素治疗:面临哪些挑战?
Hosp Formul. 1985 Dec;20(12):1247-8.
10
P & T Committee formulary requests: criteria for admission.药品与治疗学委员会处方集申请:准入标准
Hosp Formul. 1984 Oct;19(10):975-7, 980.